Vilozni D - Search Results

1

Advanced Lung Disease in Patients with Cystic Fibrosis Is Associated with Low Diffusion capacity.

Vilozni D, Dagan A, Sarouk I, Bar-Aluma BE, Ashkenazi M, Bezalel Y, Efrati O. Vilozni D, et al. Isr Med Assoc J. 2020 Dec;22(12):770-774. Isr Med Assoc J. 2020. PMID: 33381950 Free article.

2

Nutritional Status in Childhood as a Prognostic Factor in Patients with Cystic Fibrosis.

Ashkenazi M, Nathan N, Sarouk I, Aluma BEB, Dagan A, Bezalel Y, Keler S, Vilozni D, Efrati O. Ashkenazi M, et al. Among authors: vilozni d. Lung. 2019 Jun;197(3):371-376. doi: 10.1007/s00408-019-00218-3. Epub 2019 Mar 18. Lung. 2019. PMID: 30887107

3

Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?

Vilozni D, Lavie M, Sarouk I, Efrati O. Vilozni D, et al. Am J Respir Crit Care Med. 2012 Jul 1;186(1):82-7. doi: 10.1164/rccm.201202-0272OC. Epub 2012 Apr 26. Am J Respir Crit Care Med. 2012. PMID: 22538801

4

Cough characteristics and FVC maneuver in cystic fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Efrati O. Vilozni D, et al. Respir Care. 2014 Dec;59(12):1912-7. doi: 10.4187/respcare.03290. Epub 2014 Sep 23. Respir Care. 2014. PMID: 25249647 Free article.

5

Several siblings with Cystic Fibrosis as a risk factor for poor outcome.

Lavie M, Shemer O, Sarouk I, Bar Aluma Be, Dagan A, Efrati O, Vilozni D. Lavie M, et al. Among authors: vilozni d. Respir Med. 2015 Jan;109(1):74-8. doi: 10.1016/j.rmed.2014.11.012. Epub 2014 Dec 9. Respir Med. 2015. PMID: 25528949 Free article.

6

Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Dagan A, Keller N, Vilozni D, Ramon-Saraf R, Bar BE, Sarouk I, Ashkenazi M, Lavie M, Efrati O. Dagan A, et al. Among authors: vilozni d. Med Sci Monit. 2015 Jun 30;21:1889-94. doi: 10.12659/MSM.893643. Med Sci Monit. 2015. PMID: 26125407 Free PMC article.

7

The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.

Sokol G, Vilozni D, Hakimi R, Lavie M, Sarouk I, Bat-El Bar, Dagan A, Ofek M, Efrati O. Sokol G, et al. Among authors: vilozni d. Respir Care. 2015 Dec;60(12):1819-25. doi: 10.4187/respcare.04008. Epub 2015 Sep 15. Respir Care. 2015. PMID: 26374905 Free article.

8

Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.

Lavie M, Fisher D, Vilozni D, Forschmidt R, Sarouk I, Kanety H, Hemi R, Efrati O, Modan-Moses D. Lavie M, et al. Among authors: vilozni d. Diabetes Res Clin Pract. 2015 Dec;110(3):276-84. doi: 10.1016/j.diabres.2015.10.007. Epub 2015 Oct 14. Diabetes Res Clin Pract. 2015. PMID: 26508676

9

Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Segel MJ, Efrati O. Vilozni D, et al. Ann Am Thorac Soc. 2016 Jun;13(6):825-32. doi: 10.1513/AnnalsATS.201508-485OC. Ann Am Thorac Soc. 2016. PMID: 27219817

10

The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.

Vilozni D, Dagan A, Lavie M, Sarouk I, Bar-Aluma BE, Ashkenazi M, Mendelovich SL, Betzalel Y, Efrati O. Vilozni D, et al. Respir Care. 2018 Aug;63(8):981-987. doi: 10.4187/respcare.05920. Epub 2018 Jul 17. Respir Care. 2018. PMID: 30018173 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters